Predictors for clinical efficacy
| Age | NS (−5.78, 4.43)* |
| BMI | 0.01 (0.57, 4.27)* |
| Log EuroSCORE | NS (−9.68, 4.67)* |
| Mechanism of MR | NS† |
| Gender | NS† |
| Previous myocardial infarction | NS† |
| Previous CABG | NS† |
| Congestive heart failure before MitraClip | NS† |
| MR grade at discharge (1+ vs 2+ vs > 2+) | 0.0000002† |
Association between baseline variables and the combined clinical endpoint (freedom from death at 6 months, freedom from MR grade ≥3+ at 6 months, freedom from postimplant congestive heart failure and freedom from reoperation at 6 months).
*p Value, Wilcoxon t test (95% CI).
†χ2 Test.
BMI, body mass index; CABG, coronary artery bypass graft; EuroSCORE, European System for Cardiac Operative Risk Evaluation; MR, mitral regurgitation.